image
Healthcare - Biotechnology - NASDAQ - US
$ 1.18
-5.6 %
$ 63.8 M
Market Cap
3.47
P/E
BALANCE SHEET
182 M ASSETS
46.14%
75.5 M LIABILITIES
54.49%
107 M EQUITY
40.77%
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition Spero Therapeutics, Inc.
image
Current Assets 131 M
Cash & Short-Term Investments 76.3 M
Receivables 50.7 M
Other Current Assets 4.18 M
Non-Current Assets 51.2 M
Long-Term Investments 0
PP&E 4.16 M
Other Non-Current Assets 47 M
Current Liabilities 37.2 M
Accounts Payable 1.38 M
Short-Term Debt 3.44 M
Other Current Liabilities 32.3 M
Non-Current Liabilities 38.3 M
Long-Term Debt 3.82 M
Other Non-Current Liabilities 34.5 M

Balance Sheet

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015
ASSETS
Cash & Cash Equivalents 76.3 109.1 112.6 85.2 29.7 34.1 87.3 10.3 5.7
Short Term Investments 0 0 33.8 41.7 52.3 81.4 0 0 0
Receivables 50.7 1.1 2.6 6.2 8.5 1.3 2.9 0.3 10 K
Inventory 0 (4.5) 0 (12.2) (13.4) (8.8) (4.8) 0 0
Other Current Assets 4.2 3.4 17.7 12.1 4.8 15.0 3.7 1.3 0.3
Total Current Assets 131.2 109.1 157.9 126.9 82.0 115.4 87.3 11.9 6.0
PP&E 4.2 5.5 7.6 8.8 7.1 2.9 1.2 1.5 0.9
Intangible Assets 0 0 0 0 0 0 0 0 0
Goodwill 0 0 0 0 0 0 0 0 0
Long Term Investments 0 0 0 0 21 K 0.2 50 K 50 K 50 K
Other Long Term Assets 47.0 10.2 5.6 17.8 16.9 10.4 5.0 0.3 0.2
Other Assets 0 0 0 0 0 0 0 0 0
Total Assets 182.4 124.8 171.1 153.5 106.1 129.0 93.5 13.8 7.2
LIABILITIES
Accounts Payable 1.4 0.6 1.1 1.2 4.1 3.6 3.5 1.1 1.8
Short Term Debt 3.4 3.4 2.7 1.9 1.9 0 0 0 0
Other Current Liabilities 6.3 8.8 13.0 11.3 20.7 8.7 4.7 5.8 4.6
Total Current Liabilities 37.2 21.6 18.7 14.3 26.7 12.3 8.2 6.9 6.4
Long Term Debt 3.8 5.0 6.0 6.9 4.6 0 0 0 0
Deferred Tax Income 0 0 0.8 0 0 0 0 0 0
Other Liabilities 34.5 96 K 49.4 0.2 0.2 0.8 0.4 0.5 1.0
Total Liabilities 75.5 48.9 82.8 21.4 31.5 13.2 8.5 7.4 7.4
EQUITY
Common Stock 53 K 52 K 32 K 29 K 19 K 17 K 14 K 7.9 0
Retained Earnings (391.1) (413.9) (367.5) (277.7) (199.4) (138.5) (96.8) (45.4) (18.1)
Other Accumulative Comprehensive Income/Loss 0 0 2 K 7 K 16 K 28 K (0.6) (0.3) 11 K
Total Equity 106.9 75.9 88.3 132.0 74.6 116.2 85.3 6.4 (0.3)
Total Liabilities and Equity 182.4 124.8 171.1 153.5 106.1 129.0 93.5 13.8 7.2
SHARES OUTSTANDING
Common Shares Outstanding 52.7 37.6 30.9 22.4 18.2 16.0 2.6 6.6 6.6